baber/WOPTO huggingface dataset:
Patent EA-000559-B1 (EA)
Title: Method and apparatus for removing and utilization of mixed explosives from ammunition parts
Inventor: VINNIKOV V P
IPC: F42B33/06
Filed: 1997-08-11
Abstract: 1. A method for removing and utilization of mixed explosives from ammunition parts, based on removing explosive substances from a body applying an inert liquid heating medium, heated to the predetermined temperature and under pressure upon the explosive charge surface and further processing of the removed explosive charge, characterized in that the heating medium, not meltable in the melt of explosive charge, said heating medium is injected into an ammunition body via a displaceable perforated headpieces, than the mixture of the removed explosive charge and the heating medium are further subjected to lamination, sedimentation and continuous weighing and when a designed load is reached and the removal is ceased, the heating medium is clarified by settling in a separating container, add a predetermined amount of toluene melt, after which the heating medium is drained from the separating container to reach the designed level, and a mixture, remained in the separating container is mixed to a homogenous state and drain into a container of the explosive charge melt. 2. The method of Claim 1, characterized in that said headpiece performs in turn back and forth motion and reciprocation and rotary motion. 3. An apparatus comprising a holder with a receiving funnel, a device for feeding of the liquid heating medium, a separating container, an outlet conduit, a container of the explosive charge melt, characterized in that the headpiece, having a hollow pipe for feeding of heating medium are displaceable, the separating container is placed on a scale and provided with a stirring device and a flow damper, connected to the outlet conduit, provided with a connecting piece to feed an amount of toluene melt, besides, the separating container comprises a bottom drain connecting piece to connect it with the container of the explosive charge melt and two side connecting pieces, connecting the separating container with the device of feeding of the liquid heating medium, wherein the lower side connecting piece is arranged towards the bottom connecting piece on a level, determined by a formula: H = (V1+V2)/S, wherein V1 - a volume, occupied by the removed explosive charge and by the amount of the toluene melt; V2 - a volume, occupied by the remaining amount of the heating medium melt after drainage; S - cross-section of the separating container. 4. An apparatus of Claim 3, characterized in that said headpiece with a hollow pipe of the heating medium feed could perform in turn back and forth motion and reciprocation and rotary motion. 5. An apparatus of Claim 3, characterized in that the flow damper is provided with a slot-like drain in the bottom portion, arranged concentrically to the wall of the separating container.
Patent EA-000535-B1 (EA)
Title: Novel 1-ar(alk)-imidazolin-2-ones containing a distributed amine radicalin the 4-th position, having an anti-convulsive effect, and the process for their production
Inventor: LANKAU HANS-JOACHIM
IPC: C07D233/88
Filed: 1996-07-26
Abstract: 1. Novel compounds of general formula 1     wherein X = hydrogen, C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, halogen or R<1> and R<2> = C1-C4-alkyl, cycloalkyl or heteroalkyl or R<1> and R<2> together represent alkylene group having 2-6 carbon atoms, in which -CH2- group can be substituted with oxygen, nitrigen or sulfur. 2. A compound of Claim 1, representing: 1-phenyl-4-morpholino-omidazolin-2-on; 1-(4-methoxy)-4-piperidino-imidazolin-2-on; 1-(4-chlorophenyl)-4-morpholino-imidazolin-2-on; 1-(4-chlorophenyl)-4-piperidino-imidazolin-2-on; 1-(4-chlorophenyl)-4-dimethylamino-imidazolin-2-on; 1-(4-bromphenyl)-4-morpholino-imidazolin-2-on; 1-(3-chlorophenyl)-4-morpholino-imidazolin-2-on; 1-(4-chlorophenyl)-4-hexamethylenimino-imidazolin-2-on; 1-(4-chlorophenyl)-4-(4-methylpiperazino)-imidazolin-2-on; 1-(4-methylphenyl)-4-morpholino-imidazolin-2-on; 1-(4-chlorophenyl)-4-(cyclohexyl-methylamino)-imidazolin-2-on; 1-(4-fluorophenyl)-4-morpholino-imidazolin-2-on; 1-benzyl-4-morpholino-imidazolin-2-on. 3. A process for the production of compounds of general formula 2       wherein X = hydrogen, C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, halogen transform with secondary amine HNR<1>R<2> at a temperature between 50-160 degree C, wherein R<1> and R<2> have said value. 4. Pharmaceutical compositions, characterized in that as an active substance they comprise a compound of general formula 1 and, if necessary, pharmaceutical carrier substances and auxiliary substances. 5. Pharmaceutical compositions, characterized in that as an active substance they comprise at least one of compounds of Claim 2. 6. Use of compounds of general formula 1 for production pharmaceutical preparations for treating epilepsy. 7. Use of compounds of Claim 2 for production pharmaceutical preparations for treating epilepsy.
Patent EA-001491-B1 (EA)
Title: System for inspection of pipelines
Inventor: DAALAND ALF
IPC: G01N23/04
Filed: 1997-08-29
Abstract: 1. System for inspecting movable or deformable layers in pipelines (1), especially in the coupling between pipe parts, comprising indicators or marks (11,12) placed in chosen positions in at least one movable or deformable layer (5), e.g. polymer, being positioned between at least two layers (8,9) of a relatively hard material, e.g. steel, said indicators or marks (11,12) are made from a material and having a larger absorption of x-rays than the layers material (5), comprising an x-ray source (3), positioned on one side pipe wall of the pipeline, wherein a detector device (4) for x-rays or a photographic film being sensitive to x-rays, adapted to receive radiation and to be positioned on the opposite side of the pipe wall or said pipeline and that an x-rays picture of the pipeline is made on this basis. 2. System according to claim 1, characterized in that the marks/indicators (11,12) have a length being larger than their thickness or width. 3. System according to claim 2, characterized in that the marks/indicators (11,12) consists of parts of wires or strings of a suitable material, e.g. platinum or tungsten, with a thickness being approximately one third of the thickness of the polymer layer (5). 4. System according to claim 2 or 3, characterized in that the orientation of each of the marks/indicators (11,12) is chosen, thus providing an opportunity to find the position of the x-ray photographed structures. 5. System according to one of claims 1-4 characterized in that the marks/indicators (11,12) are positioned in at least two movable or deformable layers in pipelines (1), comprising more than two layers of the hard material (8,9). 6. System according to claim 5 characterized in that the marks/indicators (11,12) have a shape related to the polymer layer in which they are positioned. 7. System according to one of the preceding claims, characterized in that the imaging of the pipeline (1) is performed from a plurality of different directions and that a tomographic picture of the pipeline is made on this basis. 8. System according to one of the preceding claims, characterized in that the indicators (11,12) are positioned in at least one sealing ring (7) of the pipeline (1). 9. System according to one of the preceding claims, characterized in that the indicators (11,12) are positioned in a number of layers of different materials, e.g. pressure sheets and anti-creep sheets, which form said movable or deformable layer. 10. System according to one of the preceding claims, characterized in that the indicators (11,12) are mainly positioned close to the ends (2) of the interconnected pipes. 11. System according to one of the preceding claims, characterized in that the indicators are made from a corrosion resistant material.
Patent EA-003829-B1 (EA)
Title: Method for producing polymers and/or copolymers and composition adapted to administration to humans, animals or birds
Inventor: MELROSE GRAHAM JOHN HAMILTON
IPC: C08L33/02
Filed: 1996-05-30
Abstract: 1. A method for producing polymers and/or copolymers adapted to internal administration to humans, animals or birds and having the repeating polymeric unit: wherein R is H or alkyl, usually C1-4, or this unit in hydrated, hemiacetal or acetal form, characterized in that said polymers and/or copolymers are heated from a room temperature to a temperature not exceeding 100 degree C, in the presence of air and a final product is prepared having 0.1-5 moles of carboxy groups per 1 kg of polymers and/or copolymers. 2. The method according to claim 1, characterized in that said polymers and/or copolymers are heated to a temperature between 80-85 degree C. 3. The method according to claim 1 or 2, characterized in that produced polymers and/or copolymers are preferably soluble in an aqueous medium. 4. A composition adapted to internal administration to humans, animals or birds, characterized in that comprises polymers and/or copolymers produced by the method according to any one of claims 1 to 3.
Patent EA-003047-B1 (EA)
Title: Method of fetal hypoxia diagnosis
Inventor: ISRAILOVA MUSLIMA ZAINELJEVNA
IPC: G01N33/68
Filed: 2001-05-16
Abstract: A method of fetal hypoxia diagnosis comprising determining the activity of enzyme in blood, characterized in that the substratum content is additionally determined in blood: lactate, pyruvate, and phosphoenolpyruvate, and the following enzymes are used as enzymes: lactate dehydrogenase and isocytrate dehydrogenase and the fetal hypoxia is diagnosed at the lactate content higher than 1,5 millimole/l, the pyruvate higher than 0,8 millimole/l and phosphoenolpyruvate higher than 1,0 millimole/l and increasing the activity of the lactate dehydrogenase by more than 50% and the isocytrate dehydrogenase by more than 30% relative to the norm.
Patent EA-011420-B1 (EA)
Title: Prevention of hiv-infection with tmc278
Inventor: BAERT LIEVEN ELVIRE COLETTE
IPC: A61P31/18
Filed: 2006-04-04
Abstract: This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals.
Patent EA-014164-B1 (EA)
Title: Novel crystalline form of a pyridazino [4,5-b] indole derivative
Inventor: ROCCO WILLIAM L
IPC: A61K31/5025
Filed: 2006-08-24
Abstract: Disclosed are a novel crystalline form of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide; processes of preparing said crystalline form of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide; compositions comprising said form in the mixture with one or more pharmaceutically acceptable excipients, and the uses of said form.
Patent EA-015058-B1 (EA)
Title: Inner veneered glazed door
Inventor: YANKOVSKIJ IGOR VLADIMIROVICH
IPC: E06B3/70
Filed: 2009-01-14
Abstract: The invention relates to building, in particular, to a door structure for use in apartment and public buildings. An inner veneered glazed door comprises a frame with a window opening assembled from vertical, horizontal and intermediate wooden elements, front and rear faced walls secured on the frame from both sides, fillers placed into hollow space of a door leaf frame, a glazed insert mounted in the window opening and secured on the frame by means of fastening elements and wooden support and holding fillet in a cross-section with angular profile and link-up slopes at ends at 45 degrees, a lock with handles placed into a frame pit and door hinges secured thereon opposite the lock. A novel feature is characterized in that decorative inserts are additionally arranged on both sides relative to glazed insert with embossed thereto identical and coinciding by contour and visible through figured cuts, wherein wooden support and hold fillets are collected and tightly secured at ends by link-up slopes into separate quickly-removable frames, wherein holes are made in support and holding fillets for quickly-screwing in fastening elements with a pitch sufficient for tight fixation of the glazed insert jointly with decorative inserts in window opening on a door leaf frame. Each decorative insert is made of high-strength polystyrene plastic of the required color with self-adhesive base for connecting with the glazed insert and preventing its trembling. Each quickly-screwing-in fastening element is made as a wood screw with a U-shaped washer and Π-shaped cap interacting therewith.
Patent EA-013808-B1 (EA)
Title: A method of payment of travelling and control of travel documents and an automated system for the implementation thereof
Inventor: SKOROKHODOV SERGEY VLADIMIROVICH
IPC: G07B15/00
Filed: 2009-02-09
Abstract: The invention relates to the methods and facilities for automation of processes in transport. The problem is in improving the efficiency of payment of travelling and control of travel documents by increasing the collection of the payment due to exception of the travelling by a passenger without payment unnoticed. When entering a vehicle 8 by means of a device 17 of controlling the passenger traffic the number of passengers 4-6 situated in the vehicle is determined, and by means of apparatus 16 of remote discernment the availability of electronic travel documents 1, 2 is determined, and their identification is carried out. The passenger 6 without a travel document is determined, who is unable to make registration of payment through the points 14 of the registration of travelling payment. Until he does not make the payment of travelling through a terminal 18 by means of the cash resources or by a bank payment card, he is identified by the system as a person who has not paid for the travelling. The system also “watch” the registration of travelling payment by the passengers 4, 5 with the electronic travel documents 1, 2 through the points 14. Until these passengers do not make the registration of payment, they are considered as stowaways. For example, after the registration of payment a passenger 4 has a confirming receipt 3, and a passenger 5 who has not made the registration of payment, does not have such a receipt. Due to the fact that every electronic travel document has its personal identification number, determined distantly, the system has an opportunity to watch in real time the change of the passengers in the vehicle at stops and to provide a realistic picture of the number of passengers and whether they made the registration of payment or not. A module 15 analyses data collected from all elements 14, 16-18 and calculates the number of stowaways at the moment, passes these data through the channels of wireless communications 9 to the central complex 7.
Patent EA-017611-B1 (EA)
Title: Method for preparing a disorder-associated protein specific binding molecule or an antibody or a binding fragment or at least one immunoglobulin chain, binding said protein (variants), a binding molecule, an antibody, an immunoglobulin chain or a binding fragment thereof (variants), an antigen, a polynucleotide, vector and a host-cell, a composition comprising them and a kit and a method of diagnosing or treating neurological disorders by using said subjects (variants)
Inventor: NITSCH ROGER
IPC: A61K39/00
Filed: 2008-01-07
Abstract: Provided are novel specific binding molecules, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize neoepitopes of disease-associated proteins which derive from native endogenous proteins but are prevalent in the body of a patient in a variant form and/or out of their normal physiological context. In addition, pharmaceutical compositions comprising such binding molecules, antibodies and mimics thereof and methods of screening for novel binding molecules, which may or may not be antibodies as well as targets in the treatment of neurological disorders such as Alzheimer's disease are described.
Patent EA-017403-B1 (EA)
Title: Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
Inventor: CHEDOTAL ALAIN
IPC: A61K35/12
Filed: 2008-02-04
Abstract: The invention provides methods of treating diseases, disorsers or injuries involving demyelination and dysmyelination, including multiple sclerosis, by the administration of a Sema6A polypeptide.
Patent EA-015317-B1 (EA)
Title: Method for isolating cellulose and other adhesive materials during the recycling of waste plastics, in particular mixed plastics
Inventor: HOFMANN MICHAEL
IPC: B29B17/02
Filed: 2007-11-16
Abstract: The invention relates to a method for isolating cellulose and other adhesive material from waste plastics during the recycling of all types of waste plastics, in particular mixed plastics. According to said method, films and pieces consisting of thicker plastic parts of optionally pre-sorted waste plastics are mechanically pre-ground to obtain flakes or particles of a pre-determined size, any oversize material being discarded. The ground product is introduced together with water into a disc refiner, the fraction of flakes and other particles being at least 10 % of the total volume, any material adhering to the flakes is rubbed off to a considerable extent and forms a separate material and the latter is isolated from the plastic particles in an individual separation method.
Patent EA-017077-B1 (EA)
Title: Fungicidal compositions
Inventor: TOBLER HANS
IPC: A01N43/56
Filed: 2008-04-23
Abstract: A composition suitable for control of diseases caused by phytopathogens comprising: (A) a compound of Formula (I) wherein Ris difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) at least one compound selected from compounds known for their fungicidal activity; and a method of controlling diseases on useful plants, especially rust diseases on soybean plants.
Patent EA-021615-B1 (EA)
Title: Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Inventor: AHMED SALAH U
IPC: A61F6/14
Filed: 2009-02-03
Abstract: The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable mineral oil.
Patent EA-021826-B1 (EA)
Title: Improved method for synthesizing pirfenidone
Inventor: RADHAKRISHNAN RAMACHANDRAN
IPC: C07D401/10
Filed: 2010-06-02
Abstract: A process for synthesizing pirfenidone from bromobenzene having less than about 0.15% by weight dibromobenze is disclosed. Also disclosed are processes of synthesizing pirfenidone without using ethyl acetate or n-butanol, and pirfenidone having controlled levels of ethyl acetate, n-butanol, di(5-methyl-2-pyridinone)benzenes, and other impurities having specified retention times.
Patent EA-021687-B1 (EA)
Title: Telemetric system of bottomhole parameters monitoring
Inventor: BELJAKOV VIKTOR YUR EVICH
IPC: G01V1/46
Filed: 2012-02-08
Abstract: The invention relates to production of liquid hydrocarbons. A telemetric system is proposed for monitoring of bottomhole parameters, using a pipe string for transfer of data with the help of an acoustic field, which comprises a surface module of reception and processing of a signal and a bottomhole module lowered into the pipe string, and the bottomhole module includes a unit of measurement of bottomhole parameters, a unit of control of a bottomhole module, a unit of an acoustic generator, a device of connection and disconnection with a pipe from the pipe string, an actuating mechanism, and also a power supply unit. The actuating mechanism is made as capable of providing a direct acoustic contact with the surface of the internal wall of the pipe by means of pressing an element to it, which is made of a material with hardness exceeding the hardness of the pipe material, with introduction of the latter into the material of the pipe wall. The surface module of reception and signal processing is made with a function of registration of parameters of an information signal received in one or several different frequency ranges, and with a function of detection of working frequency ranges of the acoustic field by means of their selection inside frequency bands, where the level of natural and structural noise in the field of reception of the information signal on the surface is minimal relative to the level of the specified noise in other frequency bands.
Patent EA-036695-B1 (EA)
Title: Use of a composition comprising degarelix in treating prostate cancer in a subject having increased cholesterol level
Inventor: OLESEN TINE KOLD
IPC: A61P35/00
Filed: 2009-02-10
Abstract: The invention provides the use of a composition comprising degarelix in the treatment of prostate cancer in a subject having cholesterol level of more than or equal to 4 mmol/l, wherein the treatment is accompanied by reduced frequency and/or likelihood of developing cardiovascular disorders.
Patent EA-029230-B1 (EA)
Title: Computer-implemented method for determining target optical functions for a pair of ophthalmic lenses, method of optical optimization of a pair of ophthalmic lenses, method for manufacturing a pair of ophthalmic lenses, set of apparatuses for manufacturing a pair of ophthalmic lenses, optimized lens and optimized pair of lenses
Inventor: CONTET AUDE
IPC: G02C7/06
Filed: 2012-02-17
Abstract: A method for determining target optical functions for a pair of ophthalmic lenses is provided, the method comprising the steps of generating a first target optical function (OFT1) for a first lens of the pair based at least on data relating to a first eye, generating a second target optical function (OFT2) for a second lens of the pair based at least on data relating to the first eye. This method makes it possible to obtain optical functions having improved symmetry. Thus, when using the target optical functions in an optical optimization method, lenses with improved binocular properties can be obtained. The comfort of the wearer of the pair of lenses is thus improved.
Patent EA-026527-B1 (EA)
Title: Binding molecule having influenza a virus-neutralizing activity produced from human b cells
Inventor: CHANG SHIN JAE
IPC: C12N15/13
Filed: 2012-09-27
Abstract: The present invention relates to a binding molecule having influenza A virus-neutralizing activity produced from a human B cell, and the binding molecule having the influenza A virus-neutralizing activity, according to the present invention, is a binding molecule that is produced from a B cell that is selected from the blood of a patient infected with an influenza A virus, and has neutralizing activity with respect to the influenza A virus, and thus is useful in preventing and treating disease derived from the influenza A virus, and can be useful in diagnosing the influenza A virus by using the binding molecule according to the present invention.